Article Versions Notes

Baldini E, Presutti D, Favoriti P, Santini S, Papoff G, Tuccilli C, Carletti R, Di Gioia C, Lori E, Ferent IC, et al. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines. International Journal of Molecular Sciences. 2022; 23(7):3724. https://doi.org/10.3390/ijms23073724

Baldini, Enke, Dario Presutti, Pasqualino Favoriti, Simonetta Santini, Giuliana Papoff, Chiara Tuccilli, Raffaella Carletti, Cira Di Gioia, Eleonora Lori, Iulia Catalina Ferent, and et al. 2022. "In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines" International Journal of Molecular Sciences 23, no. 7: 3724. https://doi.org/10.3390/ijms23073724

Baldini, E., Presutti, D., Favoriti, P., Santini, S., Papoff, G., Tuccilli, C., Carletti, R., Di Gioia, C., Lori, E., Ferent, I. C., Gagliardi, F., Catania, A., Pironi, D., Tripodi, D., D’Andrea, V., Sorrenti, S., Ruberti, G., & Ulisse, S. (2022). In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines. International Journal of Molecular Sciences, 23(7), 3724. https://doi.org/10.3390/ijms23073724